ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
HiFiBiO, Pharmsynthez and IBCh sign Covid-19 antibody development deal pharmaceutical-technology
November 25, 2020HiFiBiO Therapeutics has entered into a partnership with Pharmsynthez and Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry RAS (IBCh) to develop and commercialise its SARS-CoV-2 neutralising antibody, HFB30132A, for Covid-19 treatment.
Pharma Sources Insight July 2025
